Literature DB >> 20715858

Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactions.

Carrie A Simpson1, Brian J Huffman, Aren E Gerdon, David E Cliffel.   

Abstract

Monolayer protected clusters (MPCs) are small, metal nanoparticles capped with thiolate ligands that have been widely studied for their size-dependent properties and for their ability to be functionalized for biological applications. Common water-soluble MPCs, functionalized by N-(2-Mercaptopropionyl)-glycine (tiopronin) or glutathione, have been used previously to interface with biological systems. These MPCs are ideal for biological applications not only due to their water-solubility but also their small size (<5 nm). These characteristics are expected to enable easy biodistribution and clearance. In this article, we show an unexpected toxicity is associated with the tiopronin monolayer protected cluster (TMPC), making it incompatible for potential in vivo applications. This toxicity is linked to significant histological damage to the renal tubules, causing mortality at concentrations above 20 μM. We further show how the incorporation of poly ethylene glycol (PEG) by a simple place-exchange reaction eliminates this toxicity. We analyzed gold content within blood and urine and found an increased lifetime of the particle within the bloodstream due to the creation of the mixed monolayer. Also shown was the elimination of kidney damage with the use of the mixed-monolayer particle via Multistix analysis, MALDI-TOF MS analysis, and histological examination. Final immunological analysis showed no effect on white blood cell (WBC) count for the unmodified particle and a surprising increase in WBC count with the injection of mixed monolayer particles at concentrations higher than 30 μM, suggesting that there may be an immune response to these mixed monolayer nanoparticles at high concentrations; therefore, special attention should be focused on selecting the best capping ligands for use in vivo. These findings make the mixed monolayer an excellent candidate for further biological applications using water-soluble nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20715858      PMCID: PMC2989342          DOI: 10.1021/tx100209t

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  36 in total

1.  Multifunctional gold nanoparticle-peptide complexes for nuclear targeting.

Authors:  Alexander G Tkachenko; Huan Xie; Donna Coleman; Wilhelm Glomm; Joseph Ryan; Miles F Anderson; Stefan Franzen; Daniel L Feldheim
Journal:  J Am Chem Soc       Date:  2003-04-23       Impact factor: 15.419

2.  Hemagglutinin linear epitope presentation on monolayer-protected clusters elicits strong antibody binding.

Authors:  Aren E Gerdon; David W Wright; David E Cliffel
Journal:  Biomacromolecules       Date:  2005 Nov-Dec       Impact factor: 6.988

3.  A rapid, simple, and humane method for submandibular bleeding of mice using a lancet.

Authors:  William T Golde; Peter Gollobin; Luis L Rodriguez
Journal:  Lab Anim (NY)       Date:  2005-10       Impact factor: 12.625

4.  Epitope mapping of the protective antigen of B. anthracis by using nanoclusters presenting conformational peptide epitopes.

Authors:  Aren E Gerdon; David W Wright; David E Cliffel
Journal:  Angew Chem Int Ed Engl       Date:  2006-01-16       Impact factor: 15.336

Review 5.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

6.  Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.

Authors:  Kamila Sroda; Janusz Rydlewski; Marek Langner; Arkadiusz Kozubek; Michał Grzybek; Aleksander F Sikorski
Journal:  Cell Mol Biol Lett       Date:  2005       Impact factor: 5.787

7.  Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.

Authors:  S M Moghimi; C J Porter; I S Muir; L Illum; S S Davis
Journal:  Biochem Biophys Res Commun       Date:  1991-06-14       Impact factor: 3.575

8.  The use of gold nanoparticles to enhance radiotherapy in mice.

Authors:  James F Hainfeld; Daniel N Slatkin; Henry M Smilowitz
Journal:  Phys Med Biol       Date:  2004-09-21       Impact factor: 3.609

9.  Mouse urine collection using clear plastic wrap.

Authors:  B T Kurien; R H Scofield
Journal:  Lab Anim       Date:  1999-01       Impact factor: 2.471

10.  Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers.

Authors:  Yanli Liu; Mathew K Shipton; Joseph Ryan; Eric D Kaufman; Stefan Franzen; Daniel L Feldheim
Journal:  Anal Chem       Date:  2007-02-09       Impact factor: 6.986

View more
  16 in total

1.  Biomimetic monolayer-protected gold nanoparticles for immunorecognition.

Authors:  Kellen M Harkness; Brian N Turner; Amanda C Agrawal; Yibin Zhang; John A McLean; David E Cliffel
Journal:  Nanoscale       Date:  2012-05-29       Impact factor: 7.790

Review 2.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

3.  Structure-activity relationships for biodistribution, pharmacokinetics, and excretion of atomically precise nanoclusters in a murine model.

Authors:  O Andrea Wong; Ryan J Hansen; Thomas W Ni; Christine L Heinecke; W Scott Compel; Daniel L Gustafson; Christopher J Ackerson
Journal:  Nanoscale       Date:  2013-09-17       Impact factor: 7.790

4.  Multifunctional nanoparticles as simulants for a gravimetric immunoassay.

Authors:  Scott A Miller; Leslie A Hiatt; Robert G Keil; David W Wright; David E Cliffel
Journal:  Anal Bioanal Chem       Date:  2010-11-26       Impact factor: 4.142

5.  A structural mass spectrometry strategy for the relative quantitation of ligands on mixed monolayer-protected gold nanoparticles.

Authors:  Kellen M Harkness; Brian C Hixson; Larissa S Fenn; Brian N Turner; Amanda C Rape; Carrie A Simpson; Brian J Huffman; Tracy C Okoli; John A McLean; David E Cliffel
Journal:  Anal Chem       Date:  2010-10-22       Impact factor: 6.986

6.  Short-chain PEG mixed monolayer protected gold clusters increase clearance and red blood cell counts.

Authors:  Carrie A Simpson; Amanda C Agrawal; Andrzej Balinski; Kellen M Harkness; David E Cliffel
Journal:  ACS Nano       Date:  2011-04-19       Impact factor: 15.881

Review 7.  Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies.

Authors:  Md Salman Shakil; Mahruba Sultana Niloy; Kazi Mustafa Mahmud; Mohammad Amjad Kamal; Md Asiful Islam
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

8.  Gold nanoparticles to improve HIV drug delivery.

Authors:  Carolina Garrido; Carrie A Simpson; Noelle P Dahl; Jamee Bresee; Daniel C Whitehead; Erick A Lindsey; Tyler L Harris; Candice A Smith; Carly J Carter; Daniel L Feldheim; Christian Melander; David M Margolis
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

9.  Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin.

Authors:  Joan Comenge; Carmen Sotelo; Francisco Romero; Oscar Gallego; Agustí Barnadas; Tomás García-Caballero Parada; Fernando Domínguez; Víctor F Puntes
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component.

Authors:  Rachel A Kudgus; Chad A Walden; Renee M McGovern; Joel M Reid; J David Robertson; Priyabrata Mukherjee
Journal:  Sci Rep       Date:  2014-07-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.